Decatur Capital Management’s Eli Lilly LLY Stock Holding History

Decatur Capital Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.71M	Sell	7,296 -116	-2%	-$118K	3.07%	10
2025 Q4	$7.97M	Sell	7,412 -383	-5%	-$366K	3.24%	9
2025 Q3	$5.95M	Buy	7,795 +15	+0.2%	+$11.2K	2.36%	12
2025 Q2	$6.06M	Hold	7,780	–	–	2.66%	11
2025 Q1	$6.43M	Buy	7,780 +13	+0.2%	+$10.8K	3.33%	8
2024 Q4	$6M	Sell	7,767 -115	-1%	-$95.2K	2.73%	10
2024 Q3	$6.98M	Buy	7,882 +10	+0.1%	+$8.99K	3.22%	7
2024 Q2	$7.13M	Buy	7,872 +187	+2%	+$150K	3.46%	7
2024 Q1	$5.98M	Sell	7,685 -78	-1%	-$55.5K	3.25%	7
2023 Q4	$4.53M	Buy	7,763 +2,233	+40%	+$1.3M	2.71%	8
2023 Q3	$2.97M	Hold	5,530	–	–	2.14%	9
2023 Q2	$2.59M	Buy	+5,530	New	+$2.32M	1.77%	14

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Decatur Capital Management's LLY Position: Q1 2026 in Review

Decatur Capital Management reduced its Eli Lilly (LLY) stake by 1.6% in Q1 2026, selling an estimated $118K and leaving 7,296 shares worth $6.71M. The position accounts for 3.07% of the portfolio, ranked #10.

Decatur Capital Management first reported a position in LLY in Q2 2023 and has held it in 12 quarters since. The position peaked at $7.97M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Decatur Capital Management held 7,296 shares of Eli Lilly worth $6.71M as of Q1 2026.
Decatur Capital Management sold 116 Eli Lilly shares in Q1 2026, an estimated $118K.
Eli Lilly made up 3.07% of Decatur Capital Management's portfolio in Q1 2026, its #10 holding.
Decatur Capital Management first reported a position in Eli Lilly in Q2 2023 and has held it in 12 quarters since.
Decatur Capital Management's Eli Lilly position peaked at $7.97M in Q4 2025.
4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Decatur Capital Management's 13F filing for Q1 2026, filed 13 May 2026.